Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

4th Tumor Myeloid Targeting Therapies Summit 2024

Evvnt Promotion / evvnt
-
11.06.2024 - 13.06.2024  Hilton Boston Back Bay, 40 Dalton Street, 02115 Boston, Massachusetts, USA
Time: 8:00 AM - 5:00 PM
 
Temi della conferenza
The landscape of innate immune cells is rapidly advancing towards clinical applications. Multiple published studies in the last year repeatedly affirm that targeting myeloid cells rather than the cancer cells themselves can shrink tumors, further providing confidence in their potential as a clinically effective therapeutic.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/2219781-3?pid=4832

Speakers: Akshata Udyavar, Senior Director, Actym Therapeutics, Peter Ellmark, CSO, Alligator Bioscience, Stephanie Casey Parks, Principal Scientist, Amgen, and more
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/2219781-2?pid=4832
Mr. Luke Kelly
 
Categorie
Oncologia
Lingua
Inglese
Quote del Congresso
USD 2199.00 - USD 5097.00
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

European Public Health Association (EUPHA)Alumni Club Medizinische Universität WienCenter of ExcellenceÖsterreichisches Rotes KreuzCharité International AcademySwiss Tropical and Public Health InstituteEuropean Health Forum GasteinÖsterreichische Akademie der Ärzte